List of Tables

Table 1. Thrombogenic Agents Market Size & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Thrombogenic Agents Market Restraints

Table 3. Thrombogenic Agents Market Trends

Table 4. Thrombogenic Agents Industry Policy

Table 5. Global Thrombogenic Agents Revenue by Company, 2020-2025, US$ million

Table 6. Global Thrombogenic Agents Revenue Market Share by Company, 2020-2025

Table 7. Global Thrombogenic Agents Sales Volume by Company, 2020-2025, (Units)

Table 8. Global Thrombogenic Agents Sales Volume by Company, 2020-2025

Table 9. Global Thrombogenic Agents Price by Company, 2020-2025, (US$/Unit)

Table 10. Global Thrombogenic Agents Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Thrombogenic Agents Mergers & Acquisitions, Expansion Plans

Table 12. Global Thrombogenic Agents Manufacturers Product Type

Table 13. China Thrombogenic Agents Revenue by Company, 2020-2025, US$ million

Table 14. China Thrombogenic Agents Revenue Market Share by Company, 2020-2025

Table 15. China Thrombogenic Agents Sales Volume by Company, 2020-2025, (Units)

Table 16. China Thrombogenic Agents Sales Volume Market Share by Company, 2020-2025

Table 17. China Market, Thrombogenic Agents Production, Sales, Import and Export, 2020-2025, (Units)

Table 18. China Market, Thrombogenic Agents Production, Sales, Import and Export, 2020-2031, (Units)

Table 19. China Thrombogenic Agents Import & Export Trends

Table 20. Main Sources of China Thrombogenic Agents Import

Table 21. Export Destination of China Thrombogenic Agents

Table 22. Global Headquarters and Manufacturing Base of Thrombogenic Agents Manufacturers

Table 23. Global Major Manufacturers, Thrombogenic Agents Capacity Expansion and Future Plans

Table 24. Global Thrombogenic Agents Production & Forecast by Region, 2020 VS 2024 VS 2031, (Units)

Table 25. Global Thrombogenic Agents Production by Region, 2020-2025, (Units)

Table 26. Global Thrombogenic Agents Production Forecast by Region, 2026-2031, (Units)

Table 27. Global Key Players of Thrombogenic Agents Upstream (Raw Materials)

Table 28. Global Thrombogenic Agents Typical Customers

Table 29. Thrombogenic Agents Typical Distributors

Table 30. by Type, Global Thrombogenic Agents Revenue & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. by Application, Global Thrombogenic Agents Revenue & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 32. By Region, Global Thrombogenic Agents Market Size, 2020 VS 2024 VS 2031, US$ Million

Table 33. By Region, Global Thrombogenic Agents Revenue, 2020-2031, US$ Million

Table 34. By Region, Global Thrombogenic Agents Revenue, 2026-2031, US$ Million

Table 35. By Region, Global Thrombogenic Agents Sales Volume, 2020-2025, (Units)

Table 36. By Region, Global Thrombogenic Agents Sales Volume, 2020-2031, (Units)

Table 37. By Country, Global Thrombogenic Agents Revenue & CAGR，2020 VS 2024 VS 2031, US$ Million

Table 38. By Country, Global Thrombogenic Agents Revenue, 2020-2025, US$ Million

Table 39. By Country, Global Thrombogenic Agents Revenue, 2026-2031, US$ Million

Table 40. By Country, Global Thrombogenic Agents Revenue Market Share, 2020-2025

Table 41. By Country, Global Thrombogenic Agents Revenue Market Share, 2026-2031

Table 42. By Country, Global Thrombogenic Agents Sales Volume, 2020-2025, (Units)

Table 43. By Country, Global Thrombogenic Agents Sales Volume, 2026-2031, (Units)

Table 44. By Country, Global Thrombogenic Agents Sales Volume Market Share, 2020-2025

Table 45. By Country, Global Thrombogenic Agents Sales Volume Market Share, 2026-2031

Table 46. Roche Company Information, Head Office, Market Area, and Industry Position

Table 47. Roche Thrombogenic Agents Models, Specifications, and Application

Table 48. Roche Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 49. Roche Company Profile and Main Business

Table 50. Roche Recent Developments

Table 51. Merck Company Information, Head Office, Market Area, and Industry Position

Table 52. Merck Thrombogenic Agents Models, Specifications, and Application

Table 53. Merck Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 54. Merck Company Profile and Main Business

Table 55. Merck Recent Developments

Table 56. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 57. Pfizer Thrombogenic Agents Models, Specifications, and Application

Table 58. Pfizer Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 59. Pfizer Company Profile and Main Business

Table 60. Pfizer Recent Developments

Table 61. BristolMyers Squibb Company Information, Head Office, Market Area, and Industry Position

Table 62. BristolMyers Squibb Thrombogenic Agents Models, Specifications, and Application

Table 63. BristolMyers Squibb Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 64. BristolMyers Squibb Company Profile and Main Business

Table 65. BristolMyers Squibb Recent Developments

Table 66. AbbVie Company Information, Head Office, Market Area, and Industry Position

Table 67. AbbVie Thrombogenic Agents Models, Specifications, and Application

Table 68. AbbVie Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 69. AbbVie Company Profile and Main Business

Table 70. AbbVie Recent Developments

Table 71. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 72. Sanofi Thrombogenic Agents Models, Specifications, and Application

Table 73. Sanofi Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 74. Sanofi Company Profile and Main Business

Table 75. Sanofi Recent Developments

Table 76. Johnson And Johnson Company Information, Head Office, Market Area, and Industry Position

Table 77. Johnson And Johnson Thrombogenic Agents Models, Specifications, and Application

Table 78. Johnson And Johnson Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 79. Johnson And Johnson Company Profile and Main Business

Table 80. Johnson And Johnson Recent Developments

Table 81. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position

Table 82. Boehringer Ingelheim Thrombogenic Agents Models, Specifications, and Application

Table 83. Boehringer Ingelheim Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 84. Boehringer Ingelheim Company Profile and Main Business

Table 85. Boehringer Ingelheim Recent Developments

Table 86. Amgen Company Information, Head Office, Market Area, and Industry Position

Table 87. Amgen Thrombogenic Agents Models, Specifications, and Application

Table 88. Amgen Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 89. Amgen Company Profile and Main Business

Table 90. Amgen Recent Developments

Table 91. Novo Nordisk Company Information, Head Office, Market Area, and Industry Position

Table 92. Novo Nordisk Thrombogenic Agents Models, Specifications, and Application

Table 93. Novo Nordisk Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 94. Novo Nordisk Company Profile and Main Business

Table 95. Novo Nordisk Recent Developments

Table 96. Zhongbao Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 97. Zhongbao Pharmaceutical Thrombogenic Agents Models, Specifications, and Application

Table 98. Zhongbao Pharmaceutical Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 99. Zhongbao Pharmaceutical Company Profile and Main Business

Table 100. Zhongbao Pharmaceutical Recent Developments

Table 101. Tiancheng Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position

Table 102. Tiancheng Pharmaceutical Group Thrombogenic Agents Models, Specifications, and Application

Table 103. Tiancheng Pharmaceutical Group Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 104. Tiancheng Pharmaceutical Group Company Profile and Main Business

Table 105. Tiancheng Pharmaceutical Group Recent Developments

Table 106. Chongqing Laimei Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 107. Chongqing Laimei Pharmaceutical Thrombogenic Agents Models, Specifications, and Application

Table 108. Chongqing Laimei Pharmaceutical Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 109. Chongqing Laimei Pharmaceutical Company Profile and Main Business

Table 110. Chongqing Laimei Pharmaceutical Recent Developments

Table 111. Nuokang Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position

Table 112. Nuokang Pharmaceutical Group Thrombogenic Agents Models, Specifications, and Application

Table 113. Nuokang Pharmaceutical Group Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 114. Nuokang Pharmaceutical Group Company Profile and Main Business

Table 115. Nuokang Pharmaceutical Group Recent Developments

Table 116. Shanghai RAAS Blood Products Company Information, Head Office, Market Area, and Industry Position

Table 117. Shanghai RAAS Blood Products Thrombogenic Agents Models, Specifications, and Application

Table 118. Shanghai RAAS Blood Products Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 119. Shanghai RAAS Blood Products Company Profile and Main Business

Table 120. Shanghai RAAS Blood Products Recent Developments

Table 121. Shandong Taibang Biotechnology Company Information, Head Office, Market Area, and Industry Position

Table 122. Shandong Taibang Biotechnology Thrombogenic Agents Models, Specifications, and Application

Table 123. Shandong Taibang Biotechnology Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 124. Shandong Taibang Biotechnology Company Profile and Main Business

Table 125. Shandong Taibang Biotechnology Recent Developments

Table 126. Boya Biopharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 127. Boya Biopharmaceutical Thrombogenic Agents Models, Specifications, and Application

Table 128. Boya Biopharmaceutical Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 129. Boya Biopharmaceutical Company Profile and Main Business

Table 130. Boya Biopharmaceutical Recent Developments

Table 131. Chongqing Dikang Yangtze River Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 132. Chongqing Dikang Yangtze River Pharmaceutical Thrombogenic Agents Models, Specifications, and Application

Table 133. Chongqing Dikang Yangtze River Pharmaceutical Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 134. Chongqing Dikang Yangtze River Pharmaceutical Company Profile and Main Business

Table 135. Chongqing Dikang Yangtze River Pharmaceutical Recent Developments

Table 136. Wuzhong Medicine Suzhou Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 137. Wuzhong Medicine Suzhou Pharmaceutical Thrombogenic Agents Models, Specifications, and Application

Table 138. Wuzhong Medicine Suzhou Pharmaceutical Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 139. Wuzhong Medicine Suzhou Pharmaceutical Company Profile and Main Business

Table 140. Wuzhong Medicine Suzhou Pharmaceutical Recent Developments

Table 141. Jiangsu Yabang Aipson Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 142. Jiangsu Yabang Aipson Pharmaceutical Thrombogenic Agents Models, Specifications, and Application

Table 143. Jiangsu Yabang Aipson Pharmaceutical Thrombogenic Agents Sales Volume (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 144. Jiangsu Yabang Aipson Pharmaceutical Company Profile and Main Business

Table 145. Jiangsu Yabang Aipson Pharmaceutical Recent Developments

List of Figures

Figure 1. Thrombogenic Agents Picture

Figure 2. By Revenue, Global Thrombogenic Agents Market Size and Forecast, 2020-2031, US$ Million

Figure 3. By Sales Volume, Global Thrombogenic Agents Market Size and Forecast, 2020-2031, (Units)

Figure 4. Global Thrombogenic Agents Price Trend, 2020-2031, (US$/Unit)

Figure 5. By Revenue, China Thrombogenic Agents Market Size and Forecast, 2020-2031, US$ million

Figure 6. By Sales Volume, China Thrombogenic Agents Market Size and Forecast, 2020-2031, (Units)

Figure 7. China Thrombogenic Agents Price Trend, 2020-2031 (US$/Unit)

Figure 8. By Revenue, China Thrombogenic Agents Share of Global Market, 2020-2031

Figure 9. By Sales Volume, China Thrombogenic Agents Share of Global Market, 2020-2031

Figure 10. Global Thrombogenic Agents Key Participants, Market Share, 2023 VS 2024 VS 2025

Figure 11. Global Thrombogenic Agents Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 12. China Thrombogenic Agents Key Participants, Market Share, 2023 VS 2024 VS 2025

Figure 13. China Thrombogenic Agents Key Participants, Market Share, 2024

Figure 14. China Thrombogenic Agents Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2020-2025

Figure 15. Chinese Local Players, Proportion of Thrombogenic Agents Domestic VS Export, 2024

Figure 16. Global Thrombogenic Agents Capacity, Production and Capacity Utilization, 2020-2031

Figure 17. Global Thrombogenic Agents Capacity Market Share by Region, 2024 VS 2031

Figure 18. Global Thrombogenic Agents Production Market Share & Forecast by Region, 2020-2031

Figure 19. Thrombogenic Agents Industry Chain

Figure 20. Thrombogenic Agents Procurement Model

Figure 21. Thrombogenic Agents Sales Model

Figure 22. Thrombogenic Agents Sales Channels, Direct Sales, and Distribution

Figure 23. Antithrombin Ⅲ Dependent Anticoagulants

Figure 24. Vitamin K Antagonists

Figure 25. Direct Thrombin Inhibitors

Figure 26. Factor Xa Inhibitors

Figure 27. Others

Figure 28. by Type, Global Thrombogenic Agents Revenue, 2020-2031, US$ Million

Figure 29. by Type, Global Thrombogenic Agents Revenue Market Share, 2020-2031

Figure 30. by Type, Global Thrombogenic Agents Sales Volume, 2020-2031, (Units)

Figure 31. by Type, Global Thrombogenic Agents Sales Volume Market Share, 2020-2031

Figure 32. by Type, Global Thrombogenic Agents Price, 2020-2031, (US$/Unit)

Figure 33. Stop Bleeding

Figure 34. Tumor Treatment

Figure 35. Cardiovascular Disease Treatment

Figure 36. Research And Drug Development

Figure 37. Others

Figure 38. by Application, Global Thrombogenic Agents Revenue, 2020-2031, US$ Million

Figure 39. by Application, Global Thrombogenic Agents Revenue Market Share, 2020-2031

Figure 40. by Application, Global Thrombogenic Agents Sales Volume, 2020-2031, (Units)

Figure 41. by Application, Global Thrombogenic Agents Sales Volume Market Share, 2020-2031

Figure 42. by Application, Global Thrombogenic Agents Price, 2020-2031, (US$/Unit)

Figure 43. By Region, Global Thrombogenic Agents Revenue Market Share, 2020-2031

Figure 44. By Region, Global Thrombogenic Agents Sales Volume Market Share, 2020-2031

Figure 45. North America Thrombogenic Agents Revenue & Forecasts, 2020-2031, US$ Million

Figure 46. By Country, North America Thrombogenic Agents Revenue Market Share, 2024

Figure 47. Europe Thrombogenic Agents Revenue & Forecasts, 2020-2031, US$ Million

Figure 48. By Country, Europe Thrombogenic Agents Revenue Market Share, 2024

Figure 49. Asia Pacific Thrombogenic Agents Revenue & Forecasts, 2020-2031, US$ Million

Figure 50. By Country/Region, Asia Pacific Thrombogenic Agents Revenue Market Share, 2024

Figure 51. South America Thrombogenic Agents Revenue & Forecasts, 2020-2031, US$ Million

Figure 52. By Country, South America Thrombogenic Agents Revenue Market Share, 2024

Figure 53. Middle East & Africa Thrombogenic Agents Revenue & Forecasts, 2020-2031, US$ Million

Figure 54. United States Thrombogenic Agents Sales Volume, 2020-2031, (Units)

Figure 55. By Company, United States Thrombogenic Agents Market Share, 2024

Figure 56. by Type, United States Thrombogenic Agents Sales Volume Market Share, 2024 VS 2031

Figure 57. by Application, United States Thrombogenic Agents Sales Volume Market Share, 2024 VS 2031

Figure 58. Europe Thrombogenic Agents Sales Volume, 2020-2031, (Units)

Figure 59. By Company, Europe Thrombogenic Agents Market Share, 2024

Figure 60. by Type, Europe Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 61. by Application, Europe Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 62. China Thrombogenic Agents Sales Volume, 2020-2031, (Units)

Figure 63. By Company, China Thrombogenic Agents Market Share, 2024

Figure 64. by Type, China Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 65. by Application, China Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 66. Japan Thrombogenic Agents Sales Volume, 2020-2031, (Units)

Figure 67. By Company, Japan Thrombogenic Agents Market Share, 2024

Figure 68. by Type, Japan Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 69. by Application, Japan Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 70. South Korea Thrombogenic Agents Sales Volume, 2020-2031, (Units)

Figure 71. By Company, South Korea Thrombogenic Agents Market Share, 2024

Figure 72. by Type, South Korea Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 73. by Application, South Korea Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 74. Southeast Asia Thrombogenic Agents Sales Volume, 2020-2031, (Units)

Figure 75. By Company, Southeast Asia Thrombogenic Agents Market Share, 2024

Figure 76. by Type, Southeast Asia Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 77. by Application, Southeast Asia Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 78. India Thrombogenic Agents Sales Volume, 2020-2031, (Units)

Figure 79. By Company, India Thrombogenic Agents Market Share, 2024

Figure 80. by Type, India Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 81. by Application, India Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 82. Middle East & Africa Thrombogenic Agents Sales Volume, 2020-2031, (Units)

Figure 83. By Company, Middle East & Africa Thrombogenic Agents Market Share, 2024

Figure 84. by Type, Middle East & Africa Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 85. by Application, Middle East & Africa Thrombogenic Agents Market Size, Share, 2024 VS 2031

Figure 86. Research Methodology

Figure 87. Breakdown of Primary Interviews

Figure 88. Bottom-up Approaches

Figure 89. Top-down Approaches